SEC Form 4 · accession 0001638599-17-000721
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Klein
Director
Period of report
Jul 14, 2017
Accepted (ET)
Jul 21, 2017 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Jul 14, 2017 | D | 13,333 | $0.00 | D | 201,668 | D | |
| Common Stock, par value $0.001 | holding | — | — | — | 1,800 | I | By Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Restricted Stock UnitsF1,F2 | $0.00 | Jul 14, 2017 | A | 13,333 | A | — | — | Common Stock | 13,333 | 53,332 | D |
Explanation of responses
- F1The Reporting Person was granted 50,000 shares of restricted common stock of the Issuer in July 2015 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on July 15, 2016. The Reporting Person deferred the receipt of 80% of the vested shares on July 14, 2017 and instead received 13,333 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 13,333 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.
- F2Each deferred restricted stock unit will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.